Batch-Dependent Safety of the BNT162b2 mRNA COVID-19 Vaccine

white and black labeled bottle

Max Schmeling, Vibeke Manniche and Peter Riis Hansen Vaccination has been widely implemented for mitigation of coronavirus disease-2019 (Covid-19), and by 11 November 2022, 701 million doses of the BNT162b2 mRNA vaccine (Pfizer-BioNTech) had been administered and linked with 971,021 reports of suspected adverse effects (SAEs) in the European Union/European Economic Area (EU/EEA). … Unexpectedly, […]